In the present study, we show that the therapeutic efficacy of anti-PDL1 and anti-PDL2 Abs can be significantly enhanced by the timely administration of immunogenic chemotherapy and that the effectiveness of this combination is proportional to the inherent immunogenicity of the tumor. Here, CD274 is linked to neoplasm.